NATCOPHARM.NS Cash Flow
NATCO Pharma Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 6 years on file
(FY2020-21 to FY2025-26)
· fetched 2026-08-23 23:38
| Line item | FY2020-21 | FY2021-22 | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | N/A | ₹0.47 Bn | ₹8.49 Bn | ₹12.12 Bn | ₹16.97 Bn | ₹17.68 Bn | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | N/A | ₹-0.05 Bn | ₹-4.77 Bn | ₹-10.33 Bn | ₹-14.14 Bn | ₹-21.43 Bn | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | N/A | ₹0.35 Bn | ₹-3.63 Bn | ₹-2.47 Bn | ₹-2.11 Bn | ₹2.98 Bn | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | N/A | ₹0.09 Bn | ₹0.12 Bn | ₹0.07 Bn | ₹-0.22 Bn | ₹1.56 Bn | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | N/A | ₹0.85 Bn | ₹0.21 Bn | ₹-0.61 Bn | ₹0.50 Bn | ₹0.79 Bn | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | N/A | ₹0.26 Bn | ₹1.11 Bn | ₹1.32 Bn | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from NATCOPHARM.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).